BioXcel Grants Warrants for 1.35M Shares at $0.01 Exercise Price

BioXcel Therapeutics, Inc. granted warrants to its lenders to purchase up to 1,353,729 shares of common stock at an exercise price of $0.01 per share. This action was taken on April 15, 2026, pursuant to the Ninth Amendment to its Credit Agreement and Guaranty. The company also entered into a Fourth Amended and Restated Registration Rights Agreement, agreeing to register the shares issuable upon exercise of these warrants. The warrants were issued in reliance on an exemption from registration requirements under Section 4(a)(2) of the Securities Act.